The major drawback of stent implantation in native human coronary vessels is the occurrence of restenosis. Drug-eluting stents significantly reduce restenosis after percutaneous coronary intervention (PCI), but may be associated with persistent local inflammation involved in the restenosis mechanisms. In this setting coating coronary devices with anti-inflammatory agents represents an intriguing alternative to stent-based local drug delivery. The aim of the present study was to test in a porcine model the safety and efficacy of a novel Genistein-eluting balloon preceding coronary stenting. Female piglets underwent PCI in a randomized fashion with either a Genistein-eluting or a standard balloon angioplasty, followed in all vessels by bare-metal stent implantation. Pigs were sacrificed at different time points to appraise safety (i.e. endothelialization) and efficacy (i.e. anti-inflammatory and anti-proliferative effects): 1, 4, and 6-8 weeks following PCI. Overall analysis was conducted on 14 piglets. Twenty-five bare-metal stents were implanted preceded by angioplasty with a conventional balloon in 13 vessels and by the Genistein-eluted balloon in 12. No untoward effects were reported in either group. Healing and endothelialization appeared universal within 4 weeks. The Genistein-eluted balloon group disclosed a significant reduction, at four weeks from implantation, of the peri-stent inflammatory cells count (mononucleocytes 39 +/- A 32 Vs. 96 +/- A 29 per square millimetre, P = 0.019). This effect did not clearly translate into a trend towards a reduced neointimal hyperplasia at 6-8 weeks (0.13 +/- A 0.11 Vs. 0.14 +/- A 0.09, P = 0.835). This study provides the first in vivo demonstration of the anti-inflammatory effects of a Genistein-eluting balloon in PCI, warranting further research including the combination of a Genistein-eluting balloon with standard drug-eluting stent.

Effect of a novel drug-eluted balloon coated with Genistein before stent implantation in porcine coronary arteries / Imad, Sheiban; Matteo, Anselmino; Claudio, Moretti; BIONDI ZOCCAI, Giuseppe; Marco, Galloni; Cristina, Vignolini; Mario, Mattoni; Filippo, Sciuto; Pierluigi, Omede; Gian Paolo, Trevi. - In: CLINICAL RESEARCH IN CARDIOLOGY. - ISSN 1861-0684. - 97:12(2008), pp. 891-898. [10.1007/s00392-008-0705-2]

Effect of a novel drug-eluted balloon coated with Genistein before stent implantation in porcine coronary arteries

BIONDI ZOCCAI, GIUSEPPE;
2008

Abstract

The major drawback of stent implantation in native human coronary vessels is the occurrence of restenosis. Drug-eluting stents significantly reduce restenosis after percutaneous coronary intervention (PCI), but may be associated with persistent local inflammation involved in the restenosis mechanisms. In this setting coating coronary devices with anti-inflammatory agents represents an intriguing alternative to stent-based local drug delivery. The aim of the present study was to test in a porcine model the safety and efficacy of a novel Genistein-eluting balloon preceding coronary stenting. Female piglets underwent PCI in a randomized fashion with either a Genistein-eluting or a standard balloon angioplasty, followed in all vessels by bare-metal stent implantation. Pigs were sacrificed at different time points to appraise safety (i.e. endothelialization) and efficacy (i.e. anti-inflammatory and anti-proliferative effects): 1, 4, and 6-8 weeks following PCI. Overall analysis was conducted on 14 piglets. Twenty-five bare-metal stents were implanted preceded by angioplasty with a conventional balloon in 13 vessels and by the Genistein-eluted balloon in 12. No untoward effects were reported in either group. Healing and endothelialization appeared universal within 4 weeks. The Genistein-eluted balloon group disclosed a significant reduction, at four weeks from implantation, of the peri-stent inflammatory cells count (mononucleocytes 39 +/- A 32 Vs. 96 +/- A 29 per square millimetre, P = 0.019). This effect did not clearly translate into a trend towards a reduced neointimal hyperplasia at 6-8 weeks (0.13 +/- A 0.11 Vs. 0.14 +/- A 0.09, P = 0.835). This study provides the first in vivo demonstration of the anti-inflammatory effects of a Genistein-eluting balloon in PCI, warranting further research including the combination of a Genistein-eluting balloon with standard drug-eluting stent.
2008
angioplasty; developmental biology; genistein; restenosis
01 Pubblicazione su rivista::01a Articolo in rivista
Effect of a novel drug-eluted balloon coated with Genistein before stent implantation in porcine coronary arteries / Imad, Sheiban; Matteo, Anselmino; Claudio, Moretti; BIONDI ZOCCAI, Giuseppe; Marco, Galloni; Cristina, Vignolini; Mario, Mattoni; Filippo, Sciuto; Pierluigi, Omede; Gian Paolo, Trevi. - In: CLINICAL RESEARCH IN CARDIOLOGY. - ISSN 1861-0684. - 97:12(2008), pp. 891-898. [10.1007/s00392-008-0705-2]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/434284
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact